Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Philippines Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20082
20102
20113
20122
20133
20141
20152
20161
20171
20183
20191
20202
20213
20227
20234
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated10
Active, not recruiting7
Enrolling by invitation3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen4
Viatris Innovation GmbH4
Anthera Pharmaceuticals3
EMD Serono3
Eli Lilly and Company3
Human Genome Sciences Inc., a GSK Company3
AstraZeneca2
EMD Serono Research & Development Institute, Inc.2
Novartis Pharmaceuticals2
UCB Biopharma SRL2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic41
Autoimmune Diseases13
Connective Tissue Diseases7
Immune System Diseases6
Lupus Nephritis5
Lupus Erythematosus, Cutaneous4
Lupus Erythematosus, Discoid3
Nephritis2
Glomerulonephritis1
Kidney Diseases1

Trials

Showing 76 to 41 of 41. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.